Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | Jun 21, 2024 at 08:31 AM EST

Neurocrine Biosciences and Diurnal Ltd. showcased their neuroendocrinology pipeline at ENDO 2024, featuring primary data from Phase 3 studies of crinecerfont for congenital adrenal hyperplasia. Results were recently published in The New England Journal of Medicine.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.